Alison Laws

693 total citations
41 papers, 412 citations indexed

About

Alison Laws is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Alison Laws has authored 41 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cancer Research, 23 papers in Pathology and Forensic Medicine and 22 papers in Oncology. Recurrent topics in Alison Laws's work include Breast Cancer Treatment Studies (32 papers), Breast Lesions and Carcinomas (23 papers) and Breast Implant and Reconstruction (14 papers). Alison Laws is often cited by papers focused on Breast Cancer Treatment Studies (32 papers), Breast Lesions and Carcinomas (23 papers) and Breast Implant and Reconstruction (14 papers). Alison Laws collaborates with scholars based in United States, Canada and Netherlands. Alison Laws's co-authors include Tari A. King, Olga Kantor, Elizabeth A. Mittendorf, May Lynn Quan, William T. Barry, Mehra Golshan, Jiani Hu, Stuart J. Schnitt, Jungeun Choi and Rinaa S. Punglia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Alison Laws

38 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Laws United States	13	301	191	162	146	44	41	412
Manuel Fraile Spain	8	292 1.0×	233 1.2×	117 0.7×	177 1.2×	38 0.9×	22	403
Janet Litherland United Kingdom	14	206 0.7×	158 0.8×	138 0.9×	159 1.1×	68 1.5×	23	442
A.C.M. van Bommel Netherlands	13	277 0.9×	84 0.4×	198 1.2×	191 1.3×	47 1.1×	28	430
Nina Tamirisa United States	8	271 0.9×	141 0.7×	171 1.1×	83 0.6×	61 1.4×	25	375
R. Cochrane United Kingdom	8	329 1.1×	201 1.1×	100 0.6×	296 2.0×	21 0.5×	12	459
Helen A. Pass United States	8	370 1.2×	191 1.0×	84 0.5×	127 0.9×	76 1.7×	16	419
Daniela Kauer-Dorner Austria	9	276 0.9×	181 0.9×	85 0.5×	126 0.9×	68 1.5×	18	385
G Manfredi Italy	4	318 1.1×	248 1.3×	117 0.7×	198 1.4×	22 0.5×	7	380
Elvira L. Vos United States	15	220 0.7×	140 0.7×	135 0.8×	294 2.0×	73 1.7×	36	569
Gabriel Schaer Switzerland	7	253 0.8×	165 0.9×	188 1.2×	275 1.9×	43 1.0×	8	521

Countries citing papers authored by Alison Laws

Since Specialization

Citations

This map shows the geographic impact of Alison Laws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Laws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Laws more than expected).

Fields of papers citing papers by Alison Laws

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Laws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Laws. The network helps show where Alison Laws may publish in the future.

Co-authorship network of co-authors of Alison Laws

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Laws. A scholar is included among the top collaborators of Alison Laws based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Laws. Alison Laws is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weiss, Anna, Mário Antonello Rosito, Danielle Braun, et al.. (2025). Impact of the American Society of Breast Surgeons’ Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates. Annals of Surgical Oncology. 32(6). 3965–3974.

Laws, Alison, et al.. (2024). Validation of large language models for detecting pathologic complete response in breast cancer using population-based pathology reports. BMC Medical Informatics and Decision Making. 24(1). 283–283. 6 indexed citations

Myers, Sara P., Alison Laws, Laura S. Dominici, et al.. (2024). Arm morbidity and financial difficulty in breast cancer survivors. Journal of Cancer Survivorship. 20(1). 20–27. 1 indexed citations

Laws, Alison, Eshita Sharma, Kara J. Milliron, et al.. (2024). Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology. 31(5). 3120–3127. 1 indexed citations

Dominici, Laura S., Alison Laws, Mirelle Lagendijk, et al.. (2024). Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer. Annals of Surgical Oncology. 31(10). 6831–6840.

Laws, Alison, Mirelle Lagendijk, Melissa E. Hughes, et al.. (2023). Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors. Annals of Surgical Oncology. 31(3). 1623–1633. 8 indexed citations

Weiss, Anna, Olga Martínez‐Sáez, Adrienne G. Waks, et al.. (2023). Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts. Cancer. 129(12). 1836–1845. 8 indexed citations

Castillo‐Angeles, Manuel, Christina A. Minami, Alison Laws, et al.. (2023). Value of Ambulatory Modified Radical Mastectomy. Annals of Surgical Oncology. 30(8). 4637–4643. 1 indexed citations

Bychkovsky, Brittany, Alison Laws, Lydia E. Pace, et al.. (2022). Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast Cancer Research and Treatment. 193(2). 417–427. 17 indexed citations

10.

Laws, Alison, Olga Kantor, & Tari A. King. (2022). Surgical Management of the Axilla for Breast Cancer. Hematology/Oncology Clinics of North America. 37(1). 51–77. 5 indexed citations

11.

Laws, Alison, Olga Kantor, Christina A. Minami, et al.. (2022). Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. Annals of Surgical Oncology. 30(1). 68–77. 7 indexed citations

12.

Laws, Alison, Ana C. Garrido-Castro, Philip D. Poorvu, et al.. (2021). Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer. PubMed. 35(3502). 77–83. 6 indexed citations

13.

Kantor, Olga, Alison Laws, Ricardo Pastorello, et al.. (2021). Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 28(12). 7347–7355. 10 indexed citations

14.

McKevitt, Elaine, Rona Cheifetz, Alison Laws, et al.. (2021). Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy. Annals of Surgical Oncology. 28(11). 5950–5957. 22 indexed citations

15.

Laws, Alison, Rona Cheifetz, Rebecca Warburton, et al.. (2020). Nodal Staging Affects Adjuvant Treatment Choices in Elderly Patients with Clinically Node-Negative, Estrogen Receptor–Positive Breast Cancer. Current Oncology. 27(5). 250–256. 4 indexed citations

16.

Laws, Alison, et al.. (2020). Breast Biopsy During Post-treatment Surveillance of Screen-Detected Breast Cancer Patients Yields High Rates of Benign Findings. Annals of Surgical Oncology. 27(8). 2689–2697. 2 indexed citations

17.

Pastorello, Ricardo, Alison Laws, Monica McGrath, et al.. (2020). Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer. Modern Pathology. 34(5). 875–882. 23 indexed citations

18.

Olson, David, Joseph C. Dort, Adam Elwi, et al.. (2019). Same-Day Surgery for Mastectomy Patients in Alberta: A Perioperative Care Pathway and Quality Improvement Initiative. Annals of Surgical Oncology. 26(10). 3354–3360. 19 indexed citations

19.

Laws, Alison, Melissa E. Hughes, Jiani Hu, et al.. (2019). Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 26(12). 3846–3855. 20 indexed citations

20.

Laws, Alison, Kathryn D. Anderson, Jiani Hu, et al.. (2018). Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Annals of Surgical Oncology. 25(12). 3548–3555. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact